ImetelChat

https://ecancer.org/video/8014/imetelstat-provides-durable-transfusion-independence-in-heavily-transfused-non-del-5q--lr-mds-r-r-to-esas.php Dr Pierre Fenaux - Hôpital St Louis and Paris University, Paris, France Dr Pierre Fenaux presents results at the 2019 European Hematology Association (EHA) Ann...

The attendance at the annual meeting was disappointing; however I would think that the actual attendance has in the past and was again dwarfed by those participating via phone or webcast as well as those using the replay. The schedule was not conducive for local shareholders but more appropriate for...

May 16, 2019 Announcements and Press Releases and EHA Abstracts May 16, 2019 6:00 AM EDT Geron Continues to Build Senior Leadership of Its Development Team http://ir.geron.com/news-releases/news-release-details/geron-continues-build-senior-leadership-its-development-team May 16, 2019 8:00 AM EDT Ger...

Geron Continues to Build Senior Leadership of Its Development Team MENLO PARK, Calif., May 16, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that it is continuing to build the senior leadership of its development team with the addition of a Vice President, Biometrics, and...

Short-term strangle buy in Geron (TheFlyOnTheWall) THE FLY 9:30 AM ET 5/15/2019 Short-term strangle buy in Geron. The stock flat at $1.70 and 1.5K May 1.5 puts trade 5c along with 1.5K May 2 calls for a nickel. More than 3K trade in both strikes, which opens a May 1.5 - 2 strangle that expires in tw...

The confidential treatment (CT) order covers areas in regards to the contract with Parexcel , the CRO. I scanned the two exhibits 10-42 and 10-43 and looks like it covers names, phone numbers, emails, schedules, treatment of patient info, supplies, etc. I don’t think there is a lot of mystery in wha...

Karagozoglu12345, with all due respect intended in my remarks, it is in my humble experience that to continually embrace and recite the same cadre of remarks about our CEO and the JNJ/Janssen debacle is, regardless of how unintentional, an attempt to control, focus and retard the dialog and actually...

Here is the link to the Geron Schedule 14A filed with the SEC if anyone is interested in reading some of it. I meant to include it in the previous comment.

http://ir.geron.com/node/16036/html

Smuggie, I wasn’t really looking to have a dialogue on CEO compensation via this topic but you seem to insist so I will comment from my perspective. I view myself as a bit of a propeller-head so I understand nerdy quite well. I prefer to not attempt technical in my comments on this board as many of ...

Thanks Biopearl for your thoughts, you always have a balanced grasp on reality supported by facts and reasonable conclusions. Yes, the table set up as you outlined does reflect 2019 to be a pivotal year. Certainly that doesn’t just refer to MDS PIII. A pivotal year does not and should not mean every...

Okay, I expected the usual negative and off base responses to this post but maybe if you could stay on point and try to bring some reasonable contribution to what goes into making a CEO it would be appreciated. I may have understated my knowledge on what makes a CEO but I would say that primarily be...

Part II Now what traits / characteristics makes a person a candidate for becoming a CEO? Here is a very long list of characteristics often used in regards to CEOs: endless grit, resilience and perseverance, reputation awareness and protector, diversity oriented, understands the positive / negative p...

Part I: Many here, maybe most, have a better understanding than I about the role of the CEO. I have basically spent a little time Googling on the subject and summarizing some of it here. Certain far from an exhaustive effort. Most is not verbatim from these sources as I tried to summarize or read be...

http://ir.geron.com/news-releases/news-release-details/geron-expands-senior-leadership-its-development-team Geron Expands Senior Leadership of Its Development Team MENLO PARK, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced an expansion of its development ...

Thanks biopearl for another great find. Interesting site and video was quite informative, definitely worth watching! I was impressed with Dr. Mikkael A. Sekeres, who also seemed very interested in Imetelstat, maybe more so than Dr. David P. Steensma. Also, like you, I was surprised that DS didn’t pu...

I know biopearl has added the link in another post but I meant to keep this information in a single post string for easy access. While director appointments may not fall in the same category as employees, I believe it has as much if not more importance to carrying out the Geron plans and strategy. T...

Excellent thoughts biopearl! I often think we spend too much time worrying and trying to solve the science questions around Imetelstat, combinations, etc which we cannot fully see or understand from this distance. While not spending enough time on what is actually happening at Geron and at large to ...

Thanks Kmall for joining the board and presenting your campaign plans. We appreciate your energy and generous efforts to share the message. Your activism has been noticed by many and I think changes minds around this science's potential. Many of us are not and don't have to be, a scientist, doctor o...

Thanks Gentlemen, it’s nice to be able to build on what I think is rationale thinking with fair feedback and without the constant kickback. And to your point biopearl, the negative “opinion” is rarely presented on this board, which helps me maintain a level of sanity and gratitude for the platform y...

Part 2: There is the fact that what happened between the JNJ/Janssen and Geron breakup has not been adequately explained and JS has been unwilling to take investors questions or talk about it. There seemed to be actions being taken that misled many of us. While this behavior begets trust issues, I d...